Editas Medicine (NASDAQ: EDIT)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Editas Medicine (NASDAQ: EDIT) through any online brokerage.
The latest price target for Editas Medicine (NASDAQ: EDIT) was reported by Goldman Sachs on Tuesday, May 24, 2022. The analyst firm set a price target for 8.00 expecting EDIT to fall to within 12 months (a possible -44.21% downside). 12 analyst firms have reported ratings in the last year.
The stock price for Editas Medicine (NASDAQ: EDIT) is $14.34 last updated July 6, 2022, 8:00 PM UTC.
There are no upcoming dividends for Editas Medicine.
Editas Medicine’s Q2 earnings are confirmed for Wednesday, August 3, 2022.
There is no upcoming split for Editas Medicine.
Editas Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.